Cargando…

Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis

The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis (Mtb). Using (13)C isotopomer analysis, we sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mackenzie, Jared S., Lamprecht, Dirk A., Asmal, Rukaya, Adamson, John H., Borah, Khushboo, Beste, Dany J. V., Lee, Bei Shi, Pethe, Kevin, Rousseau, Simon, Krieger, Inna, Sacchettini, James C., Glasgow, Joel N., Steyn, Adrie J. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705017/ https://www.ncbi.nlm.nih.gov/pubmed/33257709 http://dx.doi.org/10.1038/s41467-020-19959-4

Ejemplares similares

NAD(H) homeostasis underlies host protection mediated by glycolytic myeloid cells in tuberculosis
por: Pacl, Hayden T., et al.
Publicado: (2023)

Glycolytic reprogramming in macrophages and MSCs during inflammation
por: Li, Xueping, et al.
Publicado: (2023)

Early glycolytic reprogramming controls microglial inflammatory activation
por: Cheng, Junjie, et al.
Publicado: (2021)

Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis
por: Jo, Min-Sik, et al.
Publicado: (2023)

Mycobacterium tuberculosis H(2)S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility
por: Kunota, Tafara T. R., et al.
Publicado: (2021)

Metabolic flux reprogramming in Mycobacterium tuberculosis-infected human macrophages
por: Borah Slater, Khushboo, et al.
Publicado: (2023)

Characterization of putative DD-carboxypeptidase-encoding genes in Mycobacterium smegmatis
por: Ealand, Christopher S., et al.
Publicado: (2019)

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming
por: Wang, Xinyue, et al.
Publicado: (2020)

The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice
por: Zhang, Yannan, et al.
Publicado: (2023)

Maleate salts of bedaquiline
por: Zeller, Matthias, et al.
Publicado: (2021)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
por: Ding, Yangming, et al.
Publicado: (2023)

Compromised Metabolic Reprogramming Is an Early Indicator of CD8(+) T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection
por: Russell, Shannon L., et al.
Publicado: (2019)

Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
por: Foo, Caroline S., et al.
Publicado: (2018)

Crystal structures of salts of bedaquiline
por: Okezue, Mercy, et al.
Publicado: (2020)

Improved Synthesis and Isolation of Bedaquiline
por: Lubanyana, Hlengekile, et al.
Publicado: (2020)

Salts and Polymorph Screens for Bedaquiline
por: Okezue, Mercy, et al.
Publicado: (2021)

Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates
por: Poh, Wilson, et al.
Publicado: (2019)

Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis
por: Saini, Vikram, et al.
Publicado: (2020)

New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
por: Lupien, Andréanne, et al.
Publicado: (2020)

Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
por: Zhao, Jiangsha, et al.
Publicado: (2017)

Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
por: Liu, Jia, et al.
Publicado: (2020)

Glycolytic reprograming in Salmonella counters NOX2-mediated dissipation of ΔpH
por: Chakraborty, Sangeeta, et al.
Publicado: (2020)

Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment
por: Mao, Na, et al.
Publicado: (2021)

Mycobacterium tuberculosis arrests host cycle at the G(1)/S transition to establish long term infection
por: Cumming, Bridgette M., et al.
Publicado: (2017)

Correction: Mycobacterium tuberculosis arrests host cycle at the G(1)/S transition to establish long term infection
por: Cumming, Bridgette M., et al.
Publicado: (2017)

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
por: Andries, Koen, et al.
Publicado: (2014)

Correction to “Improved Synthesis and Isolation of Bedaquiline”
por: Lubanyana, Hlengekile, et al.
Publicado: (2020)

Public investments in the clinical development of bedaquiline
por: Gotham, Dzintars, et al.
Publicado: (2020)

Daily Dosing for Bedaquiline in Patients with Tuberculosis
por: Salinger, David H., et al.
Publicado: (2019)

Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Nair, P., et al.
Publicado: (2022)

Primary bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Moe, S., et al.
Publicado: (2023)

Intracellular Mycobacterium tuberculosis Exploits Multiple Host Nitrogen Sources during Growth in Human Macrophages
por: Borah, Khushboo, et al.
Publicado: (2019)

Murine Norovirus Infection Results in Anti-inflammatory Response Downstream of Amino Acid Depletion in Macrophages
por: Brocard, Michèle, et al.
Publicado: (2021)

931. Host PFKFB3-dependent glycolytic reprogramming as a broad-spectrum antiviral strategy
por: Yuan, Shuofeng, et al.
Publicado: (2023)

Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
por: Lamprecht, Dirk A., et al.
Publicado: (2016)

Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages
por: Cumming, Bridgette M, et al.
Publicado: (2018)

Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)

Safety of prolonged treatment with bedaquiline in programmatic conditions
por: Zhurkin, Dzmitriy, et al.
Publicado: (2022)

“Weighting” the Evidence: How Much Bedaquiline Is Enough?
por: Brust, James C. M.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kchgcui5l95mi91euikrn8ca3p